An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
- PMID: 34342489
- DOI: 10.2217/fon-2021-0172
An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
Abstract
Triple-negative breast cancer (TNBC) is the most complex, aggressive and fatal subtype of breast cancer. Owing to the lack of targeted therapy and heterogenic nature of TNBC, chemotherapy remains the sole treatment option for TNBC, with taxanes and anthracyclines representing the general chemotherapeutic regimen in TNBC therapy. But unfortunately, patients develop resistance to the existing chemotherapeutic regimen, resulting in approximately 90% treatment failure. Breast cancer stem cells (BCSCs) are one of the major causes for the development of chemoresistance in TNBC patients. After surviving the chemotherapy damage, the presence of BCSCs results in relapse and recurrence of TNBC. Several pathways are known to regulate BCSCs' survival, such as the Wnt/β-catenin, Hedgehog, JAK/STAT and HIPPO pathways. Therefore it is imperative to target these pathways in the context of eliminating chemoresistance. In this review we will discuss the novel strategies and various preclinical and clinical studies to give an insight into overcoming TNBC chemoresistance. We present a detailed account of recent studies carried out that open an exciting perspective in relation to the mechanisms of chemoresistance.
Keywords: breast cancer; breast cancer stem cells; chemoresistance; signaling pathway; triple-negative breast cancer.
Similar articles
-
BOP1 confers chemoresistance of triple-negative breast cancer by promoting CBP-mediated β-catenin acetylation.J Pathol. 2021 Jul;254(3):265-278. doi: 10.1002/path.5676. Epub 2021 May 5. J Pathol. 2021. PMID: 33797754
-
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer.Med Oncol. 2021 Nov 23;39(1):14. doi: 10.1007/s12032-021-01610-x. Med Oncol. 2021. PMID: 34812991 Review.
-
Targeting autophagic cancer stem-cells to reverse chemoresistance in human triple negative breast cancer.Oncotarget. 2017 May 23;8(21):35205-35221. doi: 10.18632/oncotarget.16925. Oncotarget. 2017. PMID: 28445132 Free PMC article.
-
ST8SIA1 inhibition sensitizes triple negative breast cancer to chemotherapy via suppressing Wnt/β-catenin and FAK/Akt/mTOR.Clin Transl Oncol. 2021 Apr;23(4):902-910. doi: 10.1007/s12094-020-02484-7. Epub 2020 Sep 16. Clin Transl Oncol. 2021. PMID: 32939659
-
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge.Cells. 2019 Aug 22;8(9):957. doi: 10.3390/cells8090957. Cells. 2019. PMID: 31443516 Free PMC article. Review.
Cited by
-
A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer.Med Oncol. 2023 Jun 12;40(7):202. doi: 10.1007/s12032-023-02067-w. Med Oncol. 2023. PMID: 37308611
-
Hexachlorobenzene as a differential modulator of the conventional and metronomic chemotherapy response in triple negative breast cancer cells.Explor Target Antitumor Ther. 2024;5(2):278-295. doi: 10.37349/etat.2024.00218. Epub 2024 Mar 21. Explor Target Antitumor Ther. 2024. PMID: 38745771 Free PMC article.
-
Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis.Immunol Res. 2023 Aug;71(4):588-599. doi: 10.1007/s12026-023-09376-2. Epub 2023 Apr 1. Immunol Res. 2023. PMID: 37004645 Review.
-
Targeting p53 misfolding conundrum by stabilizing agents and their analogs in breast cancer therapy: a comprehensive computational analysis.Front Pharmacol. 2024 Jan 10;14:1333447. doi: 10.3389/fphar.2023.1333447. eCollection 2023. Front Pharmacol. 2024. PMID: 38269278 Free PMC article.
-
Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study.Med Oncol. 2022 Jul 23;39(10):158. doi: 10.1007/s12032-022-01779-9. Med Oncol. 2022. PMID: 35870089
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources